Takeda Pharmaceuticals
At Shire, we aim to make a difference in the lives of people living with cancer. We are committed to cancer, with approved products and a pipeline of novel assets and late-stage candidates aimed at rare, difficult-to-treat or underserved cancers for which there have been little research, innovation, or treatment options. Our approach to innovation in oncology is representative of Shire’s entrepreneurial spirit and roots in biotech, and leverages our heritage and expertise in targeting rare and highly specialized conditions.